Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Sustained response following sorafenib therapy in an older adult patient with ... - UroToday PDF Print
UroTodayThe prognosis for patients with renal cell carcinoma is very poor, with a five-year survival rate of less than 10%. Sorafenib is an orally administered

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.